Altimmune Inc (GB:0A4C)

Altimmune (0A4C) Share Price & Analysis


0A4C Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$2.35 - $16.64
Previous Close$2.56
Average Volume (3M)4.70K
Market Cap
Enterprise ValueN/A
Total Cash (Recent Filing)$160.00M
Total Debt (Recent Filing)$4.17M
Price to Earnings (P/E)N/A
Nov 14, 2023
Dividend YieldN/A
Share Statistics
Shares Outstanding52,686,426
10 Day Avg. Volume3,147
30 Day Avg. Volume4,695
Standard Deviation0.15
Financial Highlights & Ratios
Price to Book (P/B)0.92
Price to Sales (P/S)126528.64
Price to Cash Flow (P/CF)-1.80
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.00
Enterprise Value/Gross Profit0.00
Enterprise Value/Ebitda0.00
Price Target Upside583.59% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4




What was Altimmune Inc’s price range in the past 12 months?
Altimmune Inc lowest share price was $2.35 and its highest was $16.64 in the past 12 months.
    What is Altimmune Inc’s market cap?
    Currently, no data Available
    When is Altimmune Inc’s upcoming earnings report date?
    Altimmune Inc’s upcoming earnings report date is Nov 14, 2023 which is in 52 days.
      How were Altimmune Inc’s earnings last quarter?
      Altimmune Inc released its earnings results on Aug 10, 2023. The company reported -$0.32 earnings per share for the quarter, beating the consensus estimate of -$0.465 by $0.145.
        Is Altimmune Inc overvalued?
        According to Wall Street analysts Altimmune Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Altimmune Inc pay dividends?
          Altimmune Inc pays a Notavailable dividend of $873 which represents an annual dividend yield of N/A. See more information on Altimmune Inc dividends here
            What is Altimmune Inc’s EPS estimate?
            Altimmune Inc’s EPS estimate is -$0.44.
              How many shares outstanding does Altimmune Inc have?
              Altimmune Inc has 52,686,424 shares outstanding.
                What happened to Altimmune Inc’s price movement after its last earnings report?
                Altimmune Inc reported an EPS of -$0.32 in its last earnings report, beating expectations of -$0.465. Following the earnings report the stock price went up 6.748%.
                  Which hedge fund is a major shareholder of Altimmune Inc?
                  Among the largest hedge funds holding Altimmune Inc’s share is Ardsley Advisory Partners. It holds Altimmune Inc’s shares valued at 4M.


                    Altimmune Stock Smart Score

                    The Altimmune Holdings stock analysis is based on the TipRanks Smart Score which is derived from 6 unique data sets including Analyst recommendations, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                    Learn more about TipRanks Smart Score

                    Company Description

                    Altimmune Inc

                    The Group is development stage company which intend to acquire an operating business, through a merger, capital stock exchange, asset acquisition or other similar business combination. The Group does not have any activities.


                    Forecast EPS vs Actual EPS

                    Similar Stocks
                    Price & Change
                    Aptevo Therapeutics
                    Aldeyra Therapeutics
                    Allogene Therapeutics

                    Popular Stocks

                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis